首頁 > 市場調查報告書 > 食物/飲料

機能性食品益生菌

市場調查報告書

商品編碼

1391984

醫用益生菌市場：依成分類型、配銷通路和地區

Medical Probiotics Market, By Ingredient Type, By Distribution Channel, By Geography

出版日期: 2023年11月06日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

醫用益生菌市場規模預計將從 2023 年的 405 億美元增至 2030 年的 622.5 億美元，預測期內複合年成長率為 6.3%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	405億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	6.30%	2030年市場規模預測	622.5億美元

圖 1. 2023 年依地區分類的醫用益生菌全球市場佔有率(%)

醫用益生菌因其潛在的健康益處而受到廣泛關注。益生菌是對人體特別是消化器官系統有益的活菌或酵母。它們天然存在於優格、酸菜和其他發酵產品等食品中。另一方面，醫用益生菌經過專門配製，可提供有針對性的健康益處。

由於人們對腸道健康重要性的認知不斷提高、慢性病患病率上升以及對自然和預防性醫療保健解決方案的需求不斷成長，醫用益生菌市場正在快速成長。有以下因素。眾所周知，醫用益生菌可以支持消化並增強免疫系統，使其成為傳統藥物的有吸引力的替代品。

市場動態：

預計醫用益生菌市場在預測期內將顯著成長。該市場的主要促進因素包括消費者對自然和預防性醫療保健選擇的需求不斷增加、慢性病患病率上升以及對腸道健康與整體健康之間聯繫的日益了解。例如，

然而，也存在阻礙市場成長的因素。主要課題是缺乏有關醫用益生菌的使用和標籤的標準化法規。因此，消費者和醫療保健專業人士對這些產品的有效性和安全性缺乏信心。此外，醫用益生菌的高價格以及僅在某些地區提供產品也可能阻礙市場成長。

儘管面臨這些課題，醫用益生菌市場仍存在一些成長機會。益生菌相關研發（R＆D）活動的增加、益生菌產品生產和市場開拓的技術進步以及醫用益生菌應用領域的擴大是推動市場成長的因素之一。

本研究的主要特點

本報告對醫用益生菌市場進行了詳細分析，包括以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
醫用益生菌市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析醫用益生菌市場的各種策略矩陣，將有助於相關人員做出決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
俄羅斯
義大利
法國
其他歐洲國家
亞太地區
中國
印度
日本
韓國
澳洲
ASEAN
其他亞太地區
拉丁美洲
阿根廷
巴西
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
北非
中部非洲

第9章競爭形勢

公司簡介
- Probi AB
- Abbott
- Lonza
- Hansen Holding A/S
- Danone SA
- Yakult Honsha Co., Ltd.
- Nestle SA
- DowDuPont Inc.
- Kerry Group plc
- BioGaia AB
- DSM
- Sun Genomics
- Evonik
- Probiotics International Limited（Protexin）
- UAS Laboratories LLC
- Analysts'Views

第10章

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI6438

The medical probiotics market size is expected to reach US$ 62.25 Bn by 2030, from US$ 40.50 Bn in 2023, at a CAGR of 6.3% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 40.50 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.30%	2030 Value Projection:	US$ 62.25 Bn

Figure 1. Global Medical Probiotics Market Share (%), By Region, 2023

Medical probiotics have gained significant attention due to their potential health benefits. Probiotics are live bacteria and yeasts that are beneficial for the human body, especially for the digestive system. They are found naturally in foods like yogurt, sauerkraut, and other fermented products. Medical probiotics, on the other hand, are specifically formulated to provide targeted health benefits.

The g medical probiotics market is growing rapidly, which is driven by factors such as the increasing awareness about the importance of gut health, rising prevalence of chronic diseases, and the growing demand for natural and preventive healthcare solutions. Medical probiotics are known to support digestion and boost the immune system, thus making them an attractive alternative to traditional medicines.

Market Dynamics:

The medical probiotics market is expected to witness significant growth during the forecast period. The key drivers of this market include the increasing consumer demand for natural and preventive healthcare options, the rising incidence of chronic diseases, and the growing understanding of the link between gut health and overall well-being.

However, there are also certain restraints that may hinder the market growth. The major challenges are the lack of standardized regulations governing the use and labeling of medical probiotics. This leads to a lack of confidence among consumers and healthcare professionals regarding the efficacy and safety of these products. The high cost of medical probiotics and the limited availability of products in certain regions may also impede the market growth.

Despite these challenges, the medical probiotics market presents several opportunities for growth. The increasing research and development (R&D) activities related to probiotics, advancements in technology for the production and delivery of probiotic products, and the expanding application areas of medical probiotics are some of the factors driving market growth.

Key Features of the Study:

This report provides in-depth analysis of the medical probiotics market, including market size (US$ Bn ) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key companies covered as a part of this study include Probi AB, Abbott, Lonza, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc, BioGaia AB, DSM, Sun Genomics, Evonik, Probiotics International Limited (Protexin), and UAS Laboratories LLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The medical probiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the medical probiotics market

Medical Probiotics Market Segmentation:

By Ingredient Type
- Bacteria
- Lactobacilli
- Bifidobacterium
- Streptococcus
- Bacillus
- Yeast
- Spore Formers
- Others
By Application
- Probiotic Food & Beverages
- Dairy Products
- Non-dairy Beverages
- Cereals
- Baked Goods
- Fermented Meat Products
- Probiotic Dietary Supplements
- Probiotics for Women's Health
- Infant Formula
- Others
By Distribution Channel
- Hypermarkets/Supermarkets
- Pharmacies/Drugstores
- Specialty Stores
- Online Sales
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East &Africa
Top Companies in Medical Probiotics Market:
- Probi AB
- Abbott
- Lonza
- Hansen Holding A/S
- Danone S.A.
- Yakult Honsha Co., Ltd.
- Nestle S.A.
- DowDuPont Inc.
- Kerry Group plc
- BioGaia AB
- DSM
- Sun Genomics
- Evonik
- Probiotics International Limited (Protexin)
- UAS Laboratories LLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Ingredient Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing product launches for women's health
- Restraints
High R&D costs and stringent regulations
- Opportunities
Facility expansion
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Medical Probiotics Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Medical Probiotics Market, By Ingredient Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Bacteria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Lactobacilli
Bifidobacterium
Streptococcus
Bacillus
Yeast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Spore Formers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Medical Probiotics Market, By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Probiotic Food & Beverages
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Dairy Products
Non-dairy Beverages
Cereals
Baked Goods
Fermented Meat Products
Probiotic Dietary Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Probiotics for Women's Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Infant Formula
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Medical Probiotics Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hypermarkets/Supermarkets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Pharmacies/Drugstores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mon)
Specialty Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Online Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Medical Probiotics Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Sub-region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Sub-region, 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Germany
U.K.
Spain
Russia
Italy
France
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
South Korea
Australia
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Argentina
Brazil
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Company Profile
- Probi AB
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Abbott
- Lonza
- Hansen Holding A/S
- Danone S.A.
- Yakult Honsha Co., Ltd.
- Nestle S.A.
- DowDuPont Inc.
- Kerry Group plc
- BioGaia AB
- DSM
- Sun Genomics
- Evonik
- Probiotics International Limited (Protexin)
- UAS Laboratories LLC
- Analysts' Views